يعرض 1 - 10 نتائج من 90 نتيجة بحث عن '"Ciardiello F."', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

    المؤلفون: Fasano M., Della Corte C. M., Viscardi G., Di Liello R., Paragliola F., Sparano F., Iacovino M. L., Castrichino A., Doria F., Sica A., Morgillo F., Colella G., Tartaro G., Cappabianca S., Testa D., Motta G., Ciardiello F.

    المساهمون: Fasano, M., Della Corte, C. M., Viscardi, G., Di Liello, R., Paragliola, F., Sparano, F., Iacovino, M. L., Castrichino, A., Doria, F., Sica, A., Morgillo, F., Colella, G., Tartaro, G., Cappabianca, S., Testa, D., Motta, G., Ciardiello, F.

    مصطلحات موضوعية: cetuximab, EGFR, HNC, HNSCC, immunotherapy

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33767760; info:eu-repo/semantics/altIdentifier/wos/WOS:000627818600001; volume:13; firstpage:1758835920949418; journal:THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY; http://hdl.handle.net/11591/453001Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102245865

    الإتاحة: https://doi.org/10.1177/1758835920949418Test
    http://hdl.handle.net/11591/453001Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer

    المؤلفون: Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C, TORCH Investigators, Calabro' L

    المساهمون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigator, Calabro', L

    مصطلحات موضوعية: Advanced non-small-cell lung cancer, Chemotherapy, EGFR, Erlotinib, First-line treatment, Health-related quality of life, Randomized trial

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23154555; info:eu-repo/semantics/altIdentifier/wos/WOS:000311387700022; volume:7; issue:12; firstpage:1830; lastpage:1844; numberofpages:15; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11392/2492624Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870327842; https://www.jto.org/article/S1556-0864Test(15)33167-1/fulltext; https://www.jto.org/action/showPdf?pii=S1556-0864Test(15)33167-1

    الإتاحة: https://doi.org/10.1097/JTO.0b013e318275b327Test
    http://hdl.handle.net/11392/2492624Test
    https://www.jto.org/article/S1556-0864Test(15)33167-1/fulltext
    https://www.jto.org/action/showPdf?pii=S1556-0864Test(15)33167-1

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer

    المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

    المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

    مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

    وصف الملف: ELETTRONICO

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
    http://hdl.handle.net/11588/519780Test


    أضف إلى المفضلة
  4. 4
    مؤتمر
    Novel anticancer drugs TLR9 agonists interfere with EGFR signaling and potently synergies with EGFR inhibitors and with bevacizumab in wild type and cetuximab-resistant colon cancer xenografts

    المؤلفون: TORTORA, GIAMPAOLO, Caputo R., Bianco R., Garofalo S., Racioppi L., De Placido S., Ciardiello F., Agrawal S., Damiano V., MELISI, Davide

    المساهمون: Tortora, Giampaolo, Caputo, R., Bianco, R., Garofalo, S., Racioppi, L., De Placido, S., Ciardiello, F., Agrawal, S., Melisi, Davide, Damiano, V.

    مصطلحات موضوعية: TLR9, EGFR, bevacizumab

    العلاقة: Gastrointestinal Cancer Symposium 2007; numberofpages:1; http://hdl.handle.net/11562/434932Test

    الإتاحة: http://hdl.handle.net/11562/434932Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    مؤتمر
    The protein kinase C beta antagonist enzastaurin (LY317615.HCl) inhibits cancer cell growth by multiple mechanisms and is active in EGFR inhibitors-resistant cancer cells

    المؤلفون: Bianco R., Damiano V., Gelardi T., Daniele G., Caputo R., Bianco A. R., Lahn M, Ciardiello F, TORTORA, GIAMPAOLO, MELISI, Davide

    المساهمون: Bianco, R., Damiano, V., Gelardi, T., Daniele, G., Caputo, R., Melisi, Davide, Bianco, A. R., Lahn, M, Ciardiello, F, Tortora, Giampaolo

    مصطلحات موضوعية: Protein kinase C beta, enzastaurin, EGFR

    العلاقة: AACR Annual Meeting 2006; numberofpages:1; http://hdl.handle.net/11562/433981Test

    الإتاحة: http://hdl.handle.net/11562/433981Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    مؤتمر
    Human cancer cells with acquired resistance to anti-EGFR therapy are inhibited by VEGF- and EGFR-receptors tyrosine kinase inhibitor ZD6474

    المؤلفون: Bianco R., Caputo R., Damiano V., Troiani T., Bianco A. R., TORTORA, GIAMPAOLO, Ciardiello F., MELISI, Davide

    المساهمون: Bianco, R., Caputo, R., Damiano, V., Troiani, T., Melisi, Davide, Bianco, A. R., Tortora, Giampaolo, Ciardiello, F.

    مصطلحات موضوعية: VEGF, EGFR, ZD6474

    العلاقة: XLV Annual Meeting of the Italian Cancer Society; numberofpages:1; journal:TUMORI; http://hdl.handle.net/11562/433977Test

    الإتاحة: http://hdl.handle.net/11562/433977Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    مؤتمر
    Gefitinib ('Iressa, ZD1839') and a second generation antisense targeting murine double minute 2 (Mdm2) synergistically inhibit tumor growth and angiogenesis in hormone-refractory prostate cancer

    المؤلفون: Bianco R., Caputo R., Damiano V., Ciardiello F., TORTORA, GIAMPAOLO, MELISI, Davide

    المساهمون: Bianco, R., Caputo, R., Damiano, V., Melisi, Davide, Ciardiello, F., Tortora, Giampaolo

    مصطلحات موضوعية: EGFR, Mdm2, prostate

    العلاقة: AACR Annual Meeting 2003; numberofpages:1; http://hdl.handle.net/11562/433975Test

    الإتاحة: http://hdl.handle.net/11562/433975Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    مؤتمر
    A selective cyclooxygenase-2 inhibitor combined with the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') and protein kinase A antisense causes cooperative tumor growth inhibition after oral administration

    المؤلفون: TORTORA, GIAMPAOLO, Caputo R., Damiano V., Bianco R., Fontanini G., Bianco A. R., Ciardiello F., MELISI, Davide

    المساهمون: Tortora, Giampaolo, Caputo, R., Damiano, V., Melisi, Davide, Bianco, R., Fontanini, G., Bianco, A. R., Ciardiello, F.

    مصطلحات موضوعية: COX2, EGFR, PKA

    العلاقة: AACR Annual Meeting; numberofpages:1; http://hdl.handle.net/11562/433973Test

    الإتاحة: http://hdl.handle.net/11562/433973Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    مؤتمر
    Cooperative antitumor and antiangiogenic activity after oral administration of a novel taxane, an antisense targeting protein kinase A and the EGF receptor inhibitor Iressa

    المؤلفون: Damiano V., Caputo R., Fontanini G., Faviana P., De Placido S., Zunino F., Bianco A. R., Ciardiello F., TORTORA, GIAMPAOLO, MELISI, Davide

    المساهمون: Damiano, V., Caputo, R., Fontanini, G., Faviana, P., Melisi, Davide, De Placido, S., Zunino, F., Bianco, A. R., Ciardiello, F., Tortora, Giampaolo

    مصطلحات موضوعية: taxane, EGFR, PKA

    العلاقة: XXVIII Meeting of the Italian Cancer Society; numberofpages:2; journal:TUMORI; http://hdl.handle.net/11562/433968Test

    الإتاحة: http://hdl.handle.net/11562/433968Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach

    المؤلفون: Carotenuto P., Roma C., Rachiglio A. M., Tatangelo F., Pinto C., Ciardiello F., Nappi O., Iaffaioli V., Botti G., Normanno N.

    المساهمون: Carotenuto, P., Roma, C., Rachiglio, A. M., Tatangelo, F., Pinto, C., Ciardiello, F., Nappi, O., Iaffaioli, V., Botti, G., Normanno, N.

    مصطلحات موضوعية: colorectal carcinoma, EGFR, KRAS, mutation, therapy, Adenocarcinoma, Cohort Studie, Colorectal Neoplasm, Human, Neoplasm Metastasi, Proto-Oncogene Protein, Proto-Oncogene Proteins p21(ras), Reproducibility of Result, Sensitivity and Specificity, ras Protein, Oligonucleotide Array Sequence Analysi, Reverse Transcriptase Polymerase Chain Reaction

    العلاقة: volume:11; issue:8; firstpage:1169; lastpage:1179; numberofpages:11; journal:PHARMACOGENOMICS; http://hdl.handle.net/11588/875865Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-77955597394

    الإتاحة: https://doi.org/10.2217/pgs.10.86Test
    http://hdl.handle.net/11588/875865Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث